Thought Leadership on Life Insurance Assets
Thought leadership on life insurance assets, longevity investing, and portfolio construction — written for allocators who want an honest account of how the asset class actually works.
The honest case against life-insurance-linked assets
No asset class deserves to be evaluated only by its proponents. This article makes the strongest honest case against life-insurance-linked investing, then offers a careful response that does not pretend the risks are smaller than they are.
Stress-testing 'uncorrelated': what we look for before calling an asset truly diversifying
The word 'uncorrelated' is one of the most overused and undertested terms in alternative investing. This article describes what a serious test of uncorrelation looks like and how insurance-linked assets stand up to it.
Where AI is actually changing underwriting — and where it's marketing
Machine learning is meaningfully changing parts of mortality underwriting. It is also being oversold in parts where the data and the science do not yet support what marketing materials claim. This article tries to draw the line honestly.
The ESG case for life settlements
Life settlements have been described, accurately or otherwise, as 'death bonds.' This article addresses the ethical question directly, examines the policyholder's perspective, and considers how the asset class actually performs against each pillar of an ESG framework.
A family office introduction to life-insurance-linked assets
Life-insurance-linked investing is a small, regulated corner of the alternative asset universe whose returns are driven by mortality, contract, and time rather than by markets. This introduction explains the asset category, the regulatory framework, and where it tends to fit in a family office's allocation.